Virtus Biotech ETF
BBP
20 hedge funds and large institutions have $16.2M invested in Virtus Biotech ETF in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 3 closing their positions.
89% more capital invested
Capital invested by funds: $8.57M → $16.2M (+$7.66M)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
7.56% more ownership
Funds ownership: 35.11% → 42.67% (+7.6%)
5% more funds holding
Funds holding: 19 → 20 (+1)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RFWA
RPg Family Wealth Advisory
Burlington,
Massachusetts
|
+$3.77M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.1M |
| 3 |
Jane Street
New York
|
+$604K |
| 4 |
SMG
Smart Money Group
Eastland,
Texas
|
+$122K |
| 5 |
APA
American Portfolios Advisors
Holbrook,
New York
|
+$48.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$226K |
| 2 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$210K |
| 3 |
Stifel Financial
St. Louis,
Missouri
|
-$150K |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
-$52K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$48.7K |
BBP Hedge Fund Activity: Q1 2019 in Review
20 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q1 2019, worth a combined $16.2M — up 89% from $8.57M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BBP positions and 3 closed out — a net gain of 1 holder — while 4 added to existing stakes and 6 trimmed.
The largest buyer was RPg Family Wealth Advisory, opening a new position worth an estimated $3.77M. The largest seller was Citadel Advisors, cutting an estimated $226K.
- 20 institutional investors held Virtus Biotech ETF (BBP) as of Q1 2019, up from 19 in Q4 2018.
- Funds reported $16.2M of Virtus Biotech ETF stock for Q1 2019, up 89% quarter-over-quarter.
- 4 funds opened new Virtus Biotech ETF positions in Q1 2019 and 3 closed out, a net change of +1 holder.
- The largest Virtus Biotech ETF buyer in Q1 2019 was RPg Family Wealth Advisory, an estimated $3.77M added.
- The largest Virtus Biotech ETF seller in Q1 2019 was Citadel Advisors, an estimated $226K sold.
Based on aggregated 13F filings for Q1 2019.